SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-135172
Filing Date
2018-04-26
Accepted
2018-04-26 17:15:32
Documents
9
Effectiveness Date
2018-04-26

Document Format Files

Seq Description Document Type Size
1 DEFA14A d527146ddefa14a.htm DEFA14A 26931
2 GRAPHIC g527146003.jpg GRAPHIC 3320
3 GRAPHIC g527146004.jpg GRAPHIC 4725
4 GRAPHIC g527146007.jpg GRAPHIC 4727
5 GRAPHIC g527146008.jpg GRAPHIC 8435
6 GRAPHIC g527146009.jpg GRAPHIC 5167
7 GRAPHIC g52714601.jpg GRAPHIC 14964
8 GRAPHIC g52714602.jpg GRAPHIC 10586
9 GRAPHIC g52714606.jpg GRAPHIC 9145
  Complete submission text file 0001193125-18-135172.txt   111412
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-14895 | Film No.: 18779699
SIC: 2834 Pharmaceutical Preparations